Status:
UNKNOWN
Optimization of Donor-Recipient Matching in Lung Transplantation
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Lung Transplant
Eligibility:
All Genders
18+ years
Brief Summary
Lung transplantation is the curative treatment for end-stage respiratory failure involving highly selected patients. In 2018, the International Transplant Registry counts 69200 lung transplants among ...
Eligibility Criteria
Inclusion
- Patients who have received a bi-lung transplant performed by the Marie Lannelongue lung transplant team between January 1, 2007 and April 30, 2021 All indications for transplantation will be considered, including retransplantation.
- French-speaking patient
Exclusion
- Patient is a minor (\<18 years old) at the time of transplantation
- Patient's refusal to participate in the study
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Patient objecting to the use of his/her data for this research
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05195853
Start Date
January 15 2022
End Date
December 31 2023
Last Update
December 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014